Molecular structure and affinity to 5-HT1A receptor of chlorophenyl(piperazinylalkyl)phthalimides

被引:0
|
作者
Chumakov, YM [1 ]
Simonov, YA
Soboleva, SG
Sava, VM
Andronati, SA
Gdaniec, M
Bocelli, G
机构
[1] Moldavian Acad Sci, Inst Appl Phys, Kishinev 2028, Moldova
[2] Ukrainian Acad Sci, AV Bogatsky Physicochem Inst, Odessa, Ukraine
[3] Adam Mickiewicz Univ, Fac Chem, PL-60780 Poznan, Poland
[4] CNR, Ctr Studio Strutturist Diffrattometr, I-43100 Parma, Italy
关键词
psychotropic agents; chlorophenyl(piperazinylalkyl)phtalimides; serotonin receptors; affinity; pharmacophore;
D O I
10.1080/10610270008027456
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
X-ray crystallography, quantum-chemical calculations and conformational analysis have been employed to study chlorophenyl(piperazinylalkyl)phthalimides, potential ligands of 5-HT1A receptor. The molecular recognition of investigated compounds by 5-HT(1A)serotonin receptor has been estimated according to their ability to inhibit the [(3)H8]-DPAT binding. The model for 5-HT1A pharmacophore has been proposed based on crystal structures of N-(aryl)piperazinyl - alkylphthalimides.
引用
收藏
页码:225 / 227
页数:3
相关论文
共 50 条
  • [41] Imipramine but not 5-HT1A receptor agonists or neuroleptics induces adaptive changes in hippocampal 5-HT1A and 5-HT4 receptors
    Zahorodna, A
    Tokarski, K
    Bijak, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 443 (1-3) : 51 - 57
  • [42] 5-HT1A receptor activation:: New molecular and neuroadaptive mechanisms of pain relief
    Colpaert, FC
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (01) : 40 - 47
  • [43] Molecular and behavioral analysis of transgenic mice overexpressing the 5-HT1A receptor gene
    Kusserow, H
    Davies, B
    Schillings, N
    Ansorge, M
    Dopatka, M
    Stroh, T
    Voits, M
    Fink, H
    Veh, R
    Theuring, F
    JOURNAL OF NEUROCHEMISTRY, 1999, 73 : S146 - S146
  • [44] Imipramine increases the 5-HT1A receptor-mediated inhibition of hippocampal neurons without changing the 5-HT1A receptor binding
    Bijak, M
    Tokarski, K
    Czyrak, A
    Mackowiak, M
    Wedzony, K
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 305 (1-3) : 79 - 85
  • [45] 5-HT1A receptor activation: short-term effects on the mRNA expression of the 5-HT1A receptor and galanin in the raphe nuclei
    Razani, H
    Hedlund, PB
    Hansson, AC
    Fuxe, K
    Ogren, SO
    NEUROREPORT, 1997, 8 (16) : 3565 - 3570
  • [46] Effect of the postsynaptic 5-HT1A receptor antagonist MM-77 on stressed mice treated with 5-HT1A receptor agents
    Alfredo, BA
    Ofir, P
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 508 (1-3) : 155 - 158
  • [47] 5-HT1A receptor as a key player in the brain 5-HT system
    Popova, Nina K.
    Naumenko, Vladimir S.
    REVIEWS IN THE NEUROSCIENCES, 2013, 24 (02) : 191 - 204
  • [48] The 5-HT1A receptor and 5-HT transporter in temporal lobe epilepsy
    Martinez, Ashley
    Finegersh, Andrey
    Cannon, Dara M.
    Dustin, Irene
    Nugent, Alison
    Herscovitch, Peter
    Theodore, William H.
    NEUROLOGY, 2013, 80 (16) : 1465 - 1471
  • [49] 5-HT1A and 5-HT7 receptor expression in the mammalian retina
    Pootanakit, K
    Brunken, WJ
    BRAIN RESEARCH, 2000, 875 (1-2) : 152 - 156
  • [50] BUSPIRONE ANALOGS AS LIGANDS OF THE 5-HT1A RECEPTOR .1. THE MOLECULAR-STRUCTURE OF BUSPIRONE AND ITS 2 ANALOGS
    CHILMONCZYK, Z
    LES, A
    WOZNIAKOWSKA, A
    CYBULSKI, J
    KOZIOL, AE
    GDANIEC, M
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (10) : 1701 - 1710